🫁 This Friday is World Lung Cancer Day. At Flomics, we’re developing RNA-based liquid biopsy tools for early, non-invasive detection. Every dataset matters. Every life matters. 🎗️ To patients, families & researchers: we see you, we work for you. #WorldLungCancerDay #EarlyDetection #Flomics

No endless waiting ⏳ No invasive procedures 💉 Just fast, accurate, and early answers ⚡ Our goal: detect cancer early through a simple blood test — powered by RNA🩸🧬 Behind every breakthrough is a dedicated team 🧬💻🧪 #LiquidBiopsy #RNA #CancerDetection #Bioinformatics #PrecisionMedicine #TeamScience

Thanks @biorxiv-bioinfo.bsky.social for hosting our new study! We’ve unpacked the findings in detail — here’s the full thread → bsky.app/profile/flom...

Fresh insights from the Flomics team! 🧬💻 Our new preprint is out: “Systematic cross-study assessment of RNA-Seq workflows for plasma cfRNA profiling” Is cfRNA the wild west of protocols? We investigated. 📄 Read it: www.biorxiv.org/cgi/content/...

Something exciting is on the way…⌛ We're bringing RNA-based diagnostics one step closer to the clinic. Stay tuned — the news drops very soon. 🚀 #LiquidBiopsy #Transcriptomics #Biomarkers #OpenScience

👋 Hi Bluesky! We’re Flomics, a biotech company focused on liquid biopsy & transcriptomics. Passionate about robust science, reproducibility & biomarker discovery. Excited to join the community — stay tuned for our first big announcement! 🚀 #LiquidBiopsy #Genomics #OpenScience